ANGO AngioDynamics, Inc. - Common Stock
$16.22
价格 · 八月 19, 2026
截至...的财报数据 七月 14, 2026
52周区间
$9–$16
99% of range
分析师评级
BUY
10 analysts
目标价
$20
+23% upside
P/E (TTM)
-18.4
ROE
-21.2%
净利润率
-11.5%
ANGO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$16.21
市值
$676M
P/E (TTM)
-18.4
每股收益 (TTM)
$-0.88
营收 (TTM)
$320M
股息收益率
—
ROE
-21.2%
负债/权益
—
52周区间
$9 – $16
ANGO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$320M
2017-05-31
→
2026-05-31
EPS
$-0.88
2017-05-31
→
2026-05-31
自由现金流
$508.0K
2017-05-31
→
2026-05-31
利润率
-11.5%
2017-05-31
→
2026-05-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ANGO
同行中位数
P/E (TTM)
-18.4
32.9
P/S (TTM) (市销率 (TTM))
2.1
4.5
P/B (市净率)
4.0
3.7
Price / FCF (股价/自由现金流)
1331.0
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ANGO
同行中位数
Gross Margin (毛利率)
54.6%
59.7%
Operating Margin (营业利润率)
-12.5%
—
Net Profit Margin (净利润率)
-11.5%
-10.3%
ROA
-13.4%
-10.8%
ROE
-21.2%
-15.7%
ROIC
-23.7%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ANGO
同行中位数
Current Ratio (流动比率)
2.2
5.5
Quick Ratio (速动比率)
1.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ANGO
同行中位数
Revenue YoY (营收同比增长)
9.5%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-1.9%
—
Revenue CAGR 5Y (营收5年复合年增长率)
1.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ANGO
同行中位数
ANGO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
10 位分析师
- 强烈买入 2 20.0%
- 买入 7 70.0%
- 持有 1 10.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
4 位分析师 · 2026-08-13
中位数
$19.50
← 低于所有目标
$16.21
最低
$17.00
最高
$24.00
中位数目标
$19.50
+20.3%
平均目标
$20.00
+23.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.09%
下次报告
九月 30, 2026
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.07 | $-0.09 | 0.02% |
| 2026年3月31日 | $0.02 | $-0.11 | 0.13% |
| 2025年12月31日 | $0.00 | $-0.10 | 0.10% |
| 2025年9月30日 | $-0.10 | $-0.12 | 0.02% |
| 2025年6月30日 | $-0.03 | $-0.12 | 0.09% |
| 2025年3月31日 | $0.03 | $-0.13 | 0.16% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 18
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $292M | $304M | $339M | $316M | $291M | $264M | $271M | $262M | $270M | $354M | $357M | |
| Cost of Revenue | $145M | $135M | $149M | $165M | $150M | $134M | $114M | $115M | $118M | $126M | $180M | $181M | |
| Gross Profit | $175M | $158M | $155M | $174M | $166M | $157M | $150M | $156M | $144M | $144M | $174M | $176M | |
| R&D Expense | $29M | $26M | $32M | $30M | $31M | $36M | $30M | $28M | $24M | $24M | $25M | $27M | |
| SG&A Expense | $44M | $42M | $41M | $40M | $38M | $36M | $38M | $35M | $31M | $31M | $31M | $30M | |
| Operating Expenses | $215M | $198M | $402M | $225M | $194M | $192M | $317M | $165M | $158M | $155M | $173M | $179M | |
| Operating Income | $-40M | $-40M | $-192M | $-51M | $-28M | $-35M | $-167M | $-9M | $-14M | $-11M | $1M | $-3M | |
| Interest Expense | · | · | $-2M | $3M | $688.0K | $861.0K | $907.0K | $5M | $3M | $3M | $3M | $3M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $11.0K | $4.0K | |
| Other Non-op | $4M | $5M | $-817.0K | $-554.0K | $-790.0K | $92.0K | $-130.0K | $-207.0K | $-3M | $-3M | $-4M | $-5M | |
| Pretax Income | $-36M | $-34M | $-192M | $-54M | $-30M | $-36M | $-168M | $-15M | $-17M | $-14M | $-3M | $-8M | |
| Income Tax | $442.0K | $-39.0K | $-7M | $-2M | $-3M | $-5M | $-1M | $-4M | $-11M | $-7M | $40M | $-5M | |
| Net Income | $-37M | $-34M | $-184M | $-52M | $-27M | $-32M | $-167M | $61M | $16M | $5M | $-44M | $-3M | |
| EPS (Basic) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 | |
| EPS (Diluted) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 | |
| Shares (Basic) | 41,526,000 | 40,853,000 | 40,181,000 | 39,480,000 | 39,009,000 | 38,342,000 | 37,961,000 | 37,485,000 | 37,075,000 | 36,617,000 | 36,161,000 | 35,683,139 | |
| Shares (Diluted) | 41,526,000 | 40,853,000 | 40,181,000 | 39,480,000 | 39,009,000 | 38,342,000 | 37,961,000 | 37,485,000 | 37,075,000 | 36,617,000 | 36,161,000 | 35,683,139 | |
| EBITDA | $-40M | $-40M | $-192M | $-51M | $-28M | $-35M | $-167M | $-9M | $11M | $13M | · | $-994.0K |
资产负债表 27
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $56M | $76M | $45M | $29M | $48M | $54M | $228M | $74M | $48M | $32M | $18M | |
| Receivables | $48M | $43M | $44M | $53M | $52M | $35M | $31M | $44M | $39M | $45M | $53M | $58M | |
| Inventory | $52M | $62M | $61M | $55M | $51M | $49M | $60M | $40M | $39M | $55M | $55M | $67M | |
| Prepaid Expense | $9M | $8M | $13M | $5M | $11M | $9M | $7M | $4M | $4M | $6M | $3M | $4M | |
| Current Assets | $163M | $168M | $193M | $164M | $143M | $141M | $153M | $315M | $168M | $154M | $146M | $151M | |
| PP&E (Net) | $27M | $32M | $36M | $44M | $45M | $37M | $28M | $24M | $26M | $45M | $48M | $54M | |
| PP&E (Gross) | · | · | $108M | $103M | $96M | $82M | $69M | $65M | $64M | $93M | $90M | $89M | |
| Accum. Depreciation | · | · | $70M | $59M | $51M | $46M | $41M | $42M | $39M | $50M | $44M | $36M | |
| Goodwill | · | · | $0 | $159M | $201M | $201M | $201M | $348M | $286M | $361M | $361M | $361M | |
| Intangibles | $67M | $69M | $77M | $111M | $152M | $169M | $197M | $145M | $113M | $146M | $167M | $182M | |
| Other Non-current Assets | $9M | $10M | $11M | $11M | $11M | $13M | $15M | $4M | $3M | $2M | $4M | $5M | |
| Total Assets | $267M | $280M | $318M | $533M | $553M | $561M | $594M | $836M | $705M | $708M | $726M | $773M | |
| Accounts Payable | $32M | $33M | $38M | $40M | $28M | $20M | $19M | $23M | $16M | $18M | $16M | $23M | |
| Accrued Liabilities | $39M | $36M | $41M | $27M | $35M | $35M | $29M | $38M | $34M | $39M | $22M | $18M | |
| Current Liabilities | $75M | $76M | $91M | $84M | $74M | $58M | $51M | $73M | $57M | $72M | $67M | $61M | |
| Capital Leases | $4M | $2M | $4M | $3M | $5M | $7M | $8M | · | · | · | · | · | |
| Other Non-current Liabilities | $16M | $17M | $16M | $3M | $5M | $9M | $9M | $521.0K | $621.0K | $850.0K | $908.0K | $0 | |
| Total Liabilities | $96M | $97M | $112M | $154M | $128M | $122M | $139M | $222M | $163M | $193M | $219M | $228M | |
| Long-term Debt | · | · | $0 | $50M | $25M | · | · | $132M | $92M | $96M | · | · | |
| Total Debt | · | · | · | · | · | · | $0 | $132M | $92M | $96M | · | $9M | |
| Common Stock | $387.0K | $385.0K | $385.0K | $382.0K | $380.0K | $377.0K | $374.0K | $372.0K | $370.0K | $367.0K | $363.0K | $360.0K | |
| Retained Earnings | $-466M | $-429M | $-395M | $-211M | $-158M | $-132M | $-100M | $66M | $5M | $-11M | $-16M | $28M | |
| Treasury Stock | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $2M | $2M | |
| AOCI | $8M | $-2M | $-4M | $-5M | $1M | $3M | $-1M | $-1M | $-952.0K | $-1M | $-791.0K | $-833.0K | |
| Stockholders' Equity | $171M | $183M | $206M | $378M | $424M | $439M | $455M | $615M | $543M | $515M | $507M | $545M | |
| Liabilities + Equity | $267M | $280M | $318M | $533M | $553M | $561M | $594M | $836M | $705M | $708M | $726M | $773M | |
| Shares Outstanding | 41,700,419 | 40,994,030 | 40,801,597 | 39,981,422 | 39,541,173 | 38,920,951 | 38,448,536 | 37,984,382 | 37,224,493 | 36,840,091 | 36,278,098 | 35,901,420 |
现金流 17
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $23M | $26M | $28M | $31M | $29M | $26M | $24M | $26M | $23M | $25M | $28M | $30M | |
| Stock-based Comp | $14M | $10M | $11M | $11M | $11M | $9M | $8M | $9M | $8M | $6M | $3M | $6M | |
| Deferred Tax | $143.0K | $-988.0K | $-8M | $-2M | $-4M | $-5M | $-2M | $-4M | $-11M | $-8M | $40M | $-5M | |
| Amort. of Intangibles | $11M | $10M | $13M | $19M | $19M | $18M | $18M | $17M | $14M | $15M | $18M | $18M | |
| Restructuring | $13M | $14M | · | · | · | · | $26.0K | $288.0K | $5M | $1M | $0 | · | |
| Operating Cash Flow | $3M | $-10M | $-28M | $78.0K | $-7M | $24M | $-15M | $37M | $41M | $56M | $45M | $26M | |
| CapEx | $3M | $4M | $3M | $4M | $4M | $5M | $7M | $3M | $2M | $3M | $2M | $11M | |
| Investing Cash Flow | $-6M | $-10M | $124M | $-10M | $-19M | $-14M | $-63M | $83M | $-4M | $-3M | $-8M | $-13M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $116M | $0 | $15M | |
| Net Debt Issued | $0 | $0 | $-50M | $-45M | $0 | $-20M | $-132M | $-15M | $-5M | $-24M | · | $-5M | |
| Stock Repurchased | $0 | $2M | $0 | $0 | · | · | · | $0 | $0 | $14M | $0 | $0 | |
| Net Stock Activity | $0 | $-2M | · | · | · | · | · | $0 | $0 | $-14M | · | · | |
| Financing Cash Flow | $564.0K | $-255.0K | $-64M | $25M | $8M | $-17M | $-95M | $34M | $-12M | $-38M | $-24M | $-10M | |
| Net Change in Cash | $-2M | $-20M | $31M | $16M | $-19M | $-6M | $-173M | $154M | $27M | $15M | $14M | $2M | |
| Taxes Paid | $405.0K | $800.0K | $455.0K | $342.0K | $329.0K | $313.0K | $682.0K | $426.0K | $36.0K | $-102.0K | $332.0K | · | |
| Free Cash Flow | $508.0K | $-15M | $-31M | $-4M | $-11M | $19M | $-22M | $34M | $39M | $53M | · | $14M | |
| Levered FCF | · | · | $-29M | $-6M | $-12M | $18M | $-23M | $30M | $32M | $51M | · | $13M |
盈利能力 8
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.6% | 53.9% | 50.9% | 51.4% | 52.4% | 53.9% | 56.9% | 57.6% | 51.4% | 50.4% | · | 49.5% | |
| Operating Margin | -12.5% | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% | -63.3% | -3.5% | 3.1% | 3.7% | · | -0.28% | |
| Net Margin | -11.5% | -11.6% | -60.7% | -15.5% | -8.4% | -10.8% | -63.1% | 22.7% | 4.7% | 1.4% | · | -0.92% | |
| Pretax Margin | -11.3% | -11.6% | -63.1% | -16.1% | -9.5% | -12.4% | -63.6% | -5.4% | 2.2% | 2.8% | · | -2.2% | |
| EBITDA Margin | -12.5% | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% | -63.3% | -3.5% | 3.1% | 3.7% | · | -0.28% | |
| ROA | -13.4% | -11.4% | -43.4% | -9.7% | -4.8% | -5.5% | -23.3% | 8.0% | 2.3% | 0.70% | · | -0.42% | |
| ROE | -21.2% | -18.4% | -86.9% | -13.5% | -6.2% | -7.0% | -31.3% | 10.5% | 3.1% | 0.98% | · | -0.60% | |
| ROIC | -23.7% | -21.8% | -90.0% | -13.0% | -5.9% | -7.0% | -36.4% | -0.95% | 3.6% | 1.1% | · | -0.07% |
流动性与偿付能力 5
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.2 | 2.1 | 2.0 | 1.9 | 2.4 | 3.0 | 4.3 | 2.9 | 2.2 | · | 2.5 | |
| Quick Ratio | 1.4 | 1.3 | 1.3 | 1.2 | 1.1 | 1.5 | 1.7 | 3.7 | 2.0 | 1.3 | · | 1.3 | |
| Debt / Equity | · | · | · | · | · | · | 0.0 | 0.2 | 0.2 | 0.2 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.2 | 0.2 | 0.2 | · | · | |
| Interest Coverage | · | · | 119.2 | -18.9 | -41.4 | -41.0 | -184.2 | -1.8 | 3.4 | 4.6 | · | -0.3 |
效率 3
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.0 | 0.7 | 0.6 | 0.6 | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| Inventory Turnover | 2.5 | 2.2 | 2.6 | 3.1 | 3.0 | 2.5 | 2.3 | 2.9 | 3.2 | 3.2 | · | 2.6 | |
| Receivables Turnover | 7.0 | 6.8 | 6.3 | 6.4 | 7.2 | 8.7 | 7.1 | 6.5 | 8.2 | 7.2 | · | 5.9 |
增长率 3
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.5% | -3.8% | -10.3% | 7.1% | 8.7% | 10.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.9% | -2.6% | 1.5% | 8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.9% | 2.1% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $320M | $292M | $304M | $339M | $316M | $291M | $264M | $271M | $262M | $270M | $354M | $357M | |
| Net Income TTM | $-37M | $-34M | $-184M | $-52M | $-27M | $-32M | $-167M | $61M | $16M | $5M | $-44M | $-3M | |
| Market Cap | $479M | $418M | $255M | $375M | $769M | $891M | $389M | $707M | $783M | $556M | · | $579M | |
| Enterprise Value | · | · | · | · | · | · | $334M | $611M | $800M | $604M | · | $569M | |
| P/E | -13.0 | -12.3 | -1.4 | -7.1 | -28.9 | -28.2 | -2.3 | 11.5 | 47.8 | 107.7 | -9.9 | -178.3 | |
| P/S | 1.5 | 1.4 | 0.8 | 1.1 | 2.4 | 3.1 | 1.5 | 2.6 | 3.0 | 2.1 | · | 1.6 | |
| P/B | 2.8 | 2.3 | 1.2 | 1.0 | 1.8 | 2.0 | 0.9 | 1.1 | 1.4 | 1.1 | · | 1.1 | |
| P / Tangible Book | 4.6 | 3.7 | 2.0 | 3.5 | 10.8 | 12.9 | 6.8 | · | · | · | · | · | |
| P / Cash Flow | 155.0 | -41.3 | -9.1 | 4804.2 | -106.9 | 37.0 | -26.7 | 18.9 | 19.0 | 10.0 | · | 22.0 | |
| P / FCF | 942.4 | -28.7 | -8.3 | -100.4 | -66.9 | 47.1 | -17.8 | 20.6 | 20.1 | 10.5 | · | 40.4 | |
| EV / EBITDA | · | · | · | · | · | · | -2.0 | -65.0 | 75.8 | 46.6 | · | -572.3 | |
| EV / FCF | · | · | · | · | · | · | -15.3 | 17.8 | 20.6 | 11.5 | · | 39.8 | |
| EV / Revenue | · | · | · | · | · | · | 1.3 | 2.3 | 3.1 | 2.2 | · | 1.6 | |
| Earnings Yield | -7.7% | -8.1% | -72.7% | -14.1% | -3.5% | -3.5% | -43.0% | 8.7% | 2.1% | 0.93% | -10.1% | -0.56% |
损益表 17
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $87M | $78M | $79M | $76M | $80M | $72M | $73M | $67M | $71M | $75M | $79M | $79M | $91M | $81M | $85M | $82M | |
| Cost of Revenue | $40M | $37M | $35M | $34M | $38M | $33M | $33M | $31M | $32M | $39M | $39M | $39M | $45M | $40M | $40M | $39M | |
| Gross Profit | $47M | $41M | $45M | $42M | $42M | $39M | $40M | $37M | $39M | $36M | $40M | $40M | $46M | $41M | $45M | $42M | |
| R&D Expense | $8M | $7M | $8M | $6M | $7M | $7M | $6M | $6M | $7M | $8M | $9M | $8M | $8M | $7M | $7M | $8M | |
| SG&A Expense | $10M | $11M | $10M | $13M | $10M | $10M | $10M | $11M | $10M | $11M | $9M | $11M | $10M | $9M | $11M | $10M | |
| Operating Expenses | $57M | $54M | $51M | $53M | $48M | $49M | $51M | $50M | $53M | $242M | $53M | $53M | $67M | $49M | $53M | $56M | |
| Operating Income | $-10M | $-13M | $-6M | $-11M | $-6M | $-10M | $-11M | $-13M | $-14M | $-200M | $-13M | $35M | $-21M | $-9M | $-8M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $-394.0K | $-534.0K | $-119.0K | · | $736.0K | $684.0K | $381.0K | |
| Other Non-op | $-735.0K | $5M | $-128.0K | $-178.0K | $-325.0K | $5M | $12.0K | $-173.0K | $-259.0K | $-238.0K | $-32.0K | $-288.0K | $-127.0K | $0 | $-252.0K | $-175.0K | |
| Pretax Income | $-11M | $-8M | $-6M | $-11M | $-6M | $-4M | $-11M | $-13M | $-14M | $-200M | $-13M | $35M | $-22M | $-10M | $-9M | $-14M | |
| Income Tax | $370.0K | $12.0K | $-5.0K | $65.0K | $-60.0K | $-2.0K | $-110.0K | $133.0K | $-692.0K | $-12M | $16M | $-11M | $-398.0K | $-179.0K | $-565.0K | $-853.0K | |
| Net Income | $-11M | $-8M | $-6M | $-11M | $-6M | $-4M | $-11M | $-13M | $-13M | $-188M | $-29M | $46M | $-21M | $-9M | $-8M | $-13M | |
| EPS (Basic) | $-0.28 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.35 | $-4.67 | $-0.72 | $1.15 | $-0.55 | $-0.24 | $-0.21 | $-0.33 | |
| EPS (Diluted) | $-0.28 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.35 | $-4.67 | $-0.72 | $1.15 | $-0.55 | $-0.24 | $-0.21 | $-0.33 | |
| Shares (Basic) | -82,786,000 | 41,596,000 | 41,542,000 | 41,174,000 | -81,575,000 | 40,853,000 | 40,922,000 | 40,653,000 | -80,114,000 | 40,234,000 | 40,219,000 | 39,842,000 | -78,821,000 | 39,509,000 | 39,490,000 | 39,302,000 | |
| Shares (Diluted) | -82,786,000 | 41,596,000 | 41,542,000 | 41,174,000 | -81,575,000 | 40,853,000 | 40,922,000 | 40,653,000 | -80,240,000 | 40,234,000 | 40,219,000 | 39,968,000 | -78,821,000 | 39,509,000 | 39,490,000 | 39,302,000 | |
| EBITDA | · | $-13M | $-6M | $-11M | · | $-10M | $-11M | $-13M | · | $-200M | $-13M | $35M | · | $-9M | $-8M | $-13M |
资产负债表 24
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $38M | $42M | $39M | $56M | $45M | $54M | $55M | $76M | $78M | $61M | $58M | · | $30M | $30M | $25M | |
| Receivables | $48M | $46M | $44M | $43M | $43M | $43M | $43M | $40M | $44M | $49M | $52M | $50M | · | $51M | $53M | $54M | |
| Inventory | $52M | $59M | $66M | $62M | $62M | $63M | $66M | $65M | $61M | $58M | $64M | $60M | · | $64M | $63M | $58M | |
| Prepaid Expense | $9M | $14M | $10M | $13M | $8M | $15M | $12M | $13M | $13M | $11M | $9M | $8M | · | $8M | $13M | $16M | |
| Current Assets | $163M | $156M | $161M | $157M | $168M | $172M | $175M | $173M | $193M | $197M | $185M | $175M | · | $153M | $159M | $151M | |
| PP&E (Net) | $27M | $29M | $31M | $31M | $32M | $33M | $33M | $34M | $36M | $37M | $43M | $43M | · | $46M | $46M | $46M | |
| Goodwill | · | · | · | · | · | · | · | · | · | $0 | $159M | $159M | · | $200M | $201M | $201M | |
| Intangibles | $67M | $65M | $67M | $68M | $69M | $71M | $73M | $76M | $77M | $82M | $104M | $107M | · | $134M | $142M | $148M | |
| Other Non-current Assets | $9M | $10M | $11M | $10M | $10M | $10M | $10M | $11M | $11M | $9M | $8M | $9M | · | $11M | $11M | $11M | |
| Total Assets | $267M | $261M | $270M | $266M | $280M | $285M | $292M | $294M | $318M | $325M | $500M | $494M | · | $543M | $558M | $558M | |
| Accounts Payable | $32M | $29M | $35M | $32M | $33M | $30M | $35M | $31M | $38M | $35M | $38M | $25M | · | $36M | $35M | $29M | |
| Accrued Liabilities | $39M | $32M | $30M | $28M | $36M | $37M | $40M | $34M | $41M | $31M | $29M | $26M | · | $22M | $27M | $26M | |
| Current Liabilities | $75M | $66M | $72M | $68M | $76M | $78M | $89M | $77M | $91M | $86M | $78M | $57M | · | $70M | $74M | $66M | |
| Capital Leases | $4M | $4M | $4M | $2M | $2M | $3M | $3M | $3M | $4M | $2M | $3M | $3M | · | $3M | $3M | $4M | |
| Other Non-current Liabilities | $16M | $17M | $17M | $14M | $17M | $17M | $12M | $16M | $16M | $14M | $3M | $3M | · | $3M | $4M | $4M | |
| Total Liabilities | $96M | $87M | $93M | $87M | $97M | $100M | $105M | $97M | $112M | $106M | $98M | $66M | · | $145M | $150M | $144M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $50M | $50M | $50M | |
| Common Stock | $387.0K | $387.0K | $386.0K | $386.0K | $385.0K | $385.0K | $384.0K | $386.0K | $385.0K | $385.0K | $383.0K | $383.0K | · | $382.0K | $381.0K | $381.0K | |
| Retained Earnings | $-466M | $-455M | $-446M | $-440M | $-429M | $-423M | $-419M | $-408M | $-395M | $-382M | $-194M | $-165M | · | $-189M | $-180M | $-171M | |
| Treasury Stock | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | · | $6M | $6M | $6M | |
| AOCI | $8M | $3M | $998.0K | $61.0K | $-2M | $-4M | $-4M | $-3M | $-4M | $-3M | $-5M | $-6M | · | $-4M | $-288.0K | $807.0K | |
| Stockholders' Equity | $171M | $173M | $176M | $179M | $183M | $186M | $187M | $197M | $206M | $219M | $401M | $428M | $378M | $398M | $408M | $414M | |
| Liabilities + Equity | $267M | $261M | $270M | $266M | $280M | $285M | $292M | $294M | $318M | $325M | $500M | $494M | · | $543M | $558M | $558M | |
| Shares Outstanding | 41,700,419 | 41,682,097 | 41,574,212 | 41,446,782 | 40,994,030 | 40,970,831 | 40,835,709 | 41,004,249 | 40,801,597 | 40,424,533 | 40,224,406 | 40,216,641 | 39,981,422 | 39,606,422 | 39,504,144 | 39,477,751 |
现金流 16
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $4M | $2M | $2M | $3M | $3M | $2M | $3M | $2M | $4M | $3M | $2M | $3M | $3M | |
| Deferred Tax | $150.0K | $57.0K | $-48.0K | $-16.0K | $-193.0K | $-207.0K | $-249.0K | $-339.0K | $-825.0K | $-12M | $16M | $-11M | $-559.0K | $-227.0K | $-618.0K | $-907.0K | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | |
| Restructuring | $3M | $5M | $2M | $2M | $2M | $3M | $5M | $4M | $9M | $5M | · | · | · | · | · | · | |
| Operating Cash Flow | $17M | $-3M | $5M | $-16M | $19M | $-13M | $2M | $-18M | $5M | $-13M | $5M | $-26M | $16M | $1M | $7M | $-25M | |
| CapEx | $413.0K | $1M | $422.0K | $731.0K | $777.0K | $2M | $797.0K | $1M | $566.0K | $607.0K | $554.0K | $791.0K | $1M | $666.0K | $1M | $809.0K | |
| Investing Cash Flow | $-1M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | $-2M | $-2M | $29M | $-2M | $98M | $-2M | $-2M | $-2M | $-4M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $70M | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $-50M | · | · | · | $25M | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $552.0K | $0 | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $-552.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-108.0K | $621.0K | $-92.0K | $143.0K | $-6M | $7M | $-1M | $-509.0K | $-5M | $694.0K | $-352.0K | $-60M | $0 | $941.0K | $103.0K | $24M | |
| Net Change in Cash | $16M | $-4M | $3M | $-17M | $11M | $-9M | $-916.0K | $-21M | $-2M | $18M | $3M | $13M | $15M | $254.0K | $5M | $-4M | |
| Free Cash Flow | · | · | · | $-17M | · | · | · | $-19M | · | · | · | $-27M | · | · | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-27M | · | · | · | $-26M |
盈利能力 8
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 52.9% | 56.4% | 55.3% | · | 54.0% | 54.8% | 54.4% | · | 47.7% | 50.9% | 50.9% | · | 50.2% | 52.8% | 51.9% | |
| Operating Margin | · | -16.5% | -7.7% | -14.1% | · | -13.9% | -15.2% | -19.4% | · | -265.9% | -16.6% | 44.5% | · | -11.1% | -9.5% | -16.3% | |
| Net Margin | · | -10.3% | -8.0% | -14.4% | · | -6.1% | -14.7% | -19.0% | · | -249.7% | -36.7% | 58.3% | · | -11.8% | -9.9% | -16.0% | |
| Pretax Margin | · | -10.3% | -8.0% | -14.3% | · | -6.1% | -14.9% | -18.8% | · | -265.7% | -16.0% | 44.3% | · | -12.0% | -10.6% | -17.0% | |
| EBITDA Margin | · | -16.5% | -7.7% | -14.1% | · | -13.9% | -15.2% | -19.4% | · | -265.9% | -16.6% | 44.5% | · | -11.1% | -9.5% | -16.3% | |
| ROA | · | -3.0% | -2.3% | -3.9% | · | -1.4% | -2.7% | -3.2% | · | -43.3% | -5.5% | 8.7% | · | -1.8% | -1.5% | -2.3% | |
| ROE | · | -4.5% | -3.5% | -5.8% | · | -2.2% | -3.6% | -4.1% | · | -60.9% | -7.2% | 10.9% | · | -2.3% | -2.0% | -3.1% | |
| ROIC | · | -7.5% | -3.5% | -6.0% | · | -5.4% | -5.9% | -6.7% | · | -85.9% | -7.5% | 10.8% | · | -2.2% | -1.9% | -3.0% |
流动性与偿付能力 3
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.4 | 2.2 | 2.3 | · | 2.2 | 2.0 | 2.3 | · | 2.3 | 2.4 | 3.1 | · | 2.2 | 2.2 | 2.3 | |
| Quick Ratio | · | 1.3 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.5 | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 507.4 | 24.6 | -294.4 | · | -12.1 | -11.9 | -34.9 |
效率 3
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | |
| Inventory Turnover | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | |
| Receivables Turnover | · | 1.8 | 1.8 | 1.8 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.7 | 1.9 | 1.8 |
估值 (TTM) 10
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $306M | $300M | $288M | · | $288M | $295M | $300M | · | $314M | $324M | $326M | · | $322M | $319M | $311M | |
| Net Income TTM | · | $-30M | $-32M | $-39M | · | $-216M | $-240M | $-184M | · | $-180M | $-1M | $15M | · | $-44M | $-39M | $-39M | |
| Market Cap | · | $477M | $516M | $425M | · | $381M | $283M | $306M | · | $222M | $263M | $323M | · | $490M | $512M | $874M | |
| P/E | · | -16.1 | -15.9 | -10.9 | · | -1.7 | -1.2 | -1.6 | · | -1.2 | -326.5 | 21.7 | · | -13.6 | -14.7 | -26.0 | |
| P/S | · | 1.6 | 1.7 | 1.5 | · | 1.3 | 1.0 | 1.0 | · | 0.7 | 0.8 | 1.0 | · | 1.5 | 1.6 | 2.8 | |
| P/B | · | 2.8 | 2.9 | 2.4 | · | 2.0 | 1.5 | 1.6 | · | 1.0 | 0.7 | 0.8 | · | 1.2 | 1.3 | 2.1 | |
| P / Tangible Book | · | 4.4 | 4.7 | 3.8 | · | 3.3 | 2.5 | 2.5 | · | 1.6 | 1.9 | 2.0 | · | 7.7 | 7.8 | 13.4 | |
| P / Cash Flow | · | · | · | -26.7 | · | · | · | -16.8 | · | · | · | -12.5 | · | · | · | -35.3 | |
| P / FCF | · | · | · | -25.5 | · | · | · | -15.8 | · | · | · | -12.1 | · | · | · | -34.2 | |
| Earnings Yield | · | -6.2% | -6.3% | -9.2% | · | -57.6% | -86.0% | -61.0% | · | -81.6% | -0.31% | 4.6% | · | -7.3% | -6.8% | -3.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | |
|---|---|---|---|---|---|
| 收入 | $320M | $292M | $304M | $339M | $316M |
| 毛利率 % | 54.6% | 53.9% | 50.9% | 51.4% | 52.4% |
| 营业利润率 % | -12.5% | -13.7% | -63.3% | -15.1% | -9.0% |
| 净收入 | $-37M | $-34M | $-184M | $-52M | $-27M |
| 稀释后每股收益 (EPS) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
资产负债表
| 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | |
|---|---|---|---|---|---|
| 流动比率 | 2.2 | 2.2 | 2.1 | 2.0 | 1.9 |
| 速动比率 | 1.4 | 1.3 | 1.3 | 1.2 | 1.1 |
现金流
| 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $508.0K | $-15M | $-31M | $-4M | $-11M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 173 家申报者 · $385.7M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 36 (+15 与上一季度对比) | 15 (-17 与上一季度对比) | 45 (-10 与上一季度对比) | 53 (+2 与上一季度对比) | -1.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 55 位内幕人士 · 24 位高管 · 17 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| James C Clemmer | President and CEO | 2026年7月22日 M | 862448 | 1 | 0 | $111500 |
| Joseph Devivo | President and CEO | 2015年9月8日 F | 198451 | 0 | 0 | $0 |
| Scott J. Solano | Interim CEO | 2011年8月3日 A | 8945 | 0 | 0 | $0 |
| Jan Keltjens | President & CEO | 2011年1月19日 F | 109276 | 0 | 0 | $0 |
| Stephen A Trowbridge | EVP and CFO | 2026年7月22日 M | 305796 | 1 | 0 | $9932 |
| Michael Greiner | EVP and CFO | 2018年7月26日 F | 22670 | 0 | 0 | $0 |
| Mark T Frost | EVP and CFO | 2015年8月6日 F | 38389 | 0 | 0 | $0 |
| Joseph D Gersuk | EVP - CFO | 2012年9月4日 F | 47275 | 0 | 0 | $0 |
| George W. Bourne IV | CTO and COO | 2014年8月6日 F | 23613 | 0 | 0 | $0 |
| Warren Nighan JR | SVP Quality and Regulatory | 2026年7月30日 S | 64745 | 0 | 1 | $-344006 |
| Laura Piccinini | SVP International | 2026年7月22日 M | 81929 | 0 | 0 | $0 |
| Chad Thomas Campbell | SVP/GM, Vascular Access | 2026年7月22日 M | 108676 | 0 | 0 | $0 |
| Lawrence T Weiss | SVP, Chief Legal Officer | 2026年7月15日 A | 112618 | 1 | 0 | $118100 |
| Scott Centea | SVP/GM, VIT | 2023年7月19日 M | 62951 | 0 | 0 | $0 |
| Dave Helsel | SVP Global Operations and R&D | 2023年7月19日 M | 34462 | 0 | 0 | $0 |
| Robert Arthur Simpson | SVP/GM, Global Vascular | 2018年7月26日 F | 17123 | 0 | 0 | $0 |
| Stark Richard | SVP, GM - Oncology | 2017年11月15日 M | 20754 | 0 | 0 | $0 |
| Charles R Greiner | VP - Global Franchise | 2016年5月6日 S | 20910 | 0 | 0 | $0 |
| John Soto | SVP and CCO | 2015年9月10日 F | 22452 | 0 | 0 | $0 |
| Matthew C Kapusta | SVP, Business Development | 2014年11月17日 F | 30062 | 0 | 0 | $0 |
| Stephen Mcgill | SVP, GM - International | 2014年1月28日 F | 20715 | 0 | 0 | $0 |
| Richard Scott Etlinger | SVP - Global Operations | 2012年8月17日 A | 11957 | 0 | 0 | $0 |
| Alan Panzer | SVP, GM - Vascular | 2012年8月17日 A | 27500 | 0 | 0 | $0 |
| Shawn P Mccarthy | SVP - General Manager | 2010年8月17日 F | 10392 | 0 | 0 | $0 |
| Lorinda Burgess | 董事 | 2026年7月15日 A | 67144 | 0 | 0 | $0 |
| Karen A Licitra | 董事 | 2026年7月15日 A | 102322 | 0 | 0 | $0 |
| Michael E Tarnoff | 董事 | 2026年7月15日 A | 95265 | 0 | 0 | $0 |
| Eileen O'Shea Auen | 董事 | 2026年7月15日 A | 116605 | 0 | 0 | $0 |
| Wesley Johnson | 董事 | 2026年7月15日 A | 155425 | 0 | 0 | $0 |
| Howard W Donnelly | 董事 | 2026年7月15日 A | 178938 | 0 | 0 | $0 |
| Jan Stern Reed | 董事 | 2026年7月15日 A | 116921 | 0 | 0 | $0 |
| Dennis S Meteny | 董事 | 2023年7月19日 A | 140019 | 0 | 0 | $0 |
| Kevin J Gould | 董事 | 2018年7月18日 A | 55124 | 0 | 0 | $0 |
| Steve Laporte | 董事 | 2018年7月18日 A | 48484 | 0 | 0 | $0 |
| Jeffrey Gold | 董事 | 2018年7月18日 A | 73209 | 0 | 0 | $0 |
| David F Burgstahler | 董事 | 2017年4月12日 S | 381406 | 0 | 0 | $0 |
| Vincent Bucci | 董事 | 2013年10月23日 A | 88312 | 0 | 0 | $0 |
| Charles Thomas Orsatti | 董事 | 2011年8月3日 A | 2000 | 0 | 0 | $0 |
| Paul S Echenberg | — | 2012年4月23日 M | 154412 | 0 | 0 | $0 |
| Harold Mapes | — | 2010年9月7日 M | 14934 | 0 | 0 | $0 |
| William M Appling | — | 2010年9月7日 M | 16636 | 0 | 0 | $0 |
| Robert M Rossell | — | 2009年10月8日 A | 8945 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 2009年2月13日 S | 100401 | 0 | 0 | $0 |
| Robert E Flaherty | — | 2008年8月6日 A | 3700 | 0 | 0 | $0 |
| Robert D Mitchell | — | 2007年8月17日 A | 1242 | 0 | 0 | $0 |
| Daniel Recinella | — | 2007年8月17日 A | 1196 | 0 | 0 | $0 |
| Brian Kunst | — | 2007年8月17日 A | 1500 | 0 | 0 | $0 |
| Joseph G Gerardi | — | 2007年8月17日 A | 5052 | 0 | 0 | $0 |
| Paul J Shea | — | 2007年8月9日 M | 2562 | 0 | 0 | $0 |
| Linda B Stern | — | 2006年12月20日 M | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 7 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Avista Capital Partners GP, LLC (2), Avista Capital Partners, L.P. (2), Avista Capital Partners (Offshore), L.P. (2), Navilyst Medical Co-Invest, LLC (2) ×5 申报 | 2017年4月28日 | — | 初始申报 | — | SEC |
| 未披露的报告人, 未披露的报告人 | 2008年12月23日 | — | 初始申报 | — | SEC |
| Estate of Howard S. Stern., Linda B. Stern. ×4 申报 | 2007年6月28日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2005年5月16日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2005年2月14日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2004年11月12日 | — | 初始申报 | 被动投资 | SEC |
| 未披露的报告人 | 2004年10月21日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 36 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GSSC · Goldman Sachs ETF Trust | 0.07% | 57598 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.04% | 90394 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.01% | 16258 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 1766 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 137468 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 203599 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.01% | 1380 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 1917 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 1398 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 110473 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1426 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 35 NS | 2026年5月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 3043 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3292 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 6685 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 23038 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 9874 NS | 2026年4月30日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 3255 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFQY · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VFMF · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月4日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IHI · iShares Trust | — | — | 2026年8月17日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | — | — | 2026年8月5日 | 每日 |